RedundantPEG-MGF is just a longer-acting version of MGF
According to the FDA, Wegovy is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater
doi: 10.3389/fvets.2025.1667501 Received 16 July 2025 Accepted 28 August 2025 Published 19 September 2025 Volume 12 - 2025 Edited by Zhenlei Zhou, Nanjing Agricultural University, China Reviewed by Shu-cheng Huang, Henan Agricultural University, China Jianzhu Liu, Shandong Agricultural University, China Updates Copyright 2025 Tan, Jiang, Zhang, Gao, Tang and Jiang
You can have the most impeccable calculations and the steadiest hand in the world, but if the peptide you start with is subpar, your research is built on a foundation of sand